Loading...

Wenzel, Lari B

TitleProfessor
InstitutionUniversity of California, Irvine
DepartmentMedicine
Address1001 Health Sciences Road
CA 92697-3950
Phone(949) 824-3926
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Stress, Immunity &Cervical Cancer: Biobehavioral Outcomes of a Randomized Trial
    NIH/NCI R01CA118136Mar 19, 2007 - Feb 28, 2014
    Role: Principal Investigator
    Psychoneuroimmunology and Cervical Cancer
    NIH/NCI R21CA098794Jul 1, 2003 - Jun 30, 2007
    Role: Principal Investigator
    Latina Cervical Cancer Survivorship
    NIH/NCI R21CA097191Aug 1, 2002 - Jul 31, 2005
    Role: Principal Investigator
    QUALITY OF LIFE OF GYNECOLOGIC CANCER SURVIVORS
    NIH/NCI R01CA079039Sep 10, 1998 - Aug 31, 2001
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. von Gruenigen VE, Huang HQ, Cella D, Zevon M, LaChance JA, Walker JL, Salani R, Modesitt SC, Morris RT, Bradley WH, Boente MP, Wenzel L. Quality of life, symptoms and care needs in patients with persistent or recurrent platinum-resistant ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 May 17. PMID: 29778506.
      View in: PubMed
    2. Goodman D, Johnson CO, Bowen D, Smith M, Wenzel L, Edwards KL. A comparison of views regarding the use of de-identified data. Transl Behav Med. 2018 Jan 29; 8(1):113-118. PMID: 29385588.
      View in: PubMed
    3. Goodman D, Bowen D, Wenzel L, Tehrani P, Fernando F, Khacheryan A, Chowdhury F, Johnson CO, Edwards K. The research participant perspective related to the conduct of genomic cohort studies: A systematic review of the quantitative literature. Transl Behav Med. 2018 Jan 29; 8(1):119-129. PMID: 29385589.
      View in: PubMed
    4. Buchbinder DK, Fortier MA, Osann K, Wilford J, Shen V, Torno L, Sender LS, Parsons SK, Wenzel L. Quality of Life Among Parents of Adolescent and Young Adult Brain Tumor Survivors. J Pediatr Hematol Oncol. 2017 Nov; 39(8):579-584. PMID: 28859042.
      View in: PubMed
    5. Goodman D, Johnson CO, Bowen D, Smith M, Wenzel L, Edwards K. De-identified genomic data sharing: the research participant perspective. J Community Genet. 2017 Jul; 8(3):173-181. PMID: 28382417.
      View in: PubMed
    6. Wenzel L, Mukamel D, Osann K, Havrilesky L, Sparks L, Lipscomb J, Wright AA, Walker J, Alvarez R, Van Le L, Robison K, Bristow R, Morgan R, Rimel BJ, Ladd H, Hsieh S, Wahi A, Cohn D. Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients. Contemp Clin Trials. 2017 Jun; 57:29-36. PMID: 28330753.
      View in: PubMed
    7. Mai PL, Piedmonte M, Han PK, Moser RP, Walker JL, Rodriguez G, Boggess J, Rutherford TJ, Zivanovic O, Cohn DE, Thigpen JT, Wenham RM, Friedlander ML, Hamilton CA, Bakkum-Gamez J, Olawaiye AB, Hensley ML, Greene MH, Huang HQ, Wenzel L. Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 04; 145(1):122-129. PMID: 28190649.
      View in: PubMed
    8. Wilford J, Buchbinder D, Fortier MA, Osann K, Shen V, Torno L, Sender LS, Parsons SK, Wenzel L. "She Was a Little Social Butterfly": A Qualitative Analysis of Parent Perception of Social Functioning in Adolescent and Young Adult Brain Tumor Survivors. J Pediatr Oncol Nurs. 2017 Jul/Aug; 34(4):239-249. PMID: 28615001.
      View in: PubMed
    9. Hyams T, Bowen DJ, Condit C, Grossman J, Fitzmaurice M, Goodman D, Wenzel L, Edwards KL. Views of Cohort Study Participants about Returning Research Results in the Context of Precision Medicine. Public Health Genomics. 2016; 19(5):269-75. PMID: 27553645.
      View in: PubMed
    10. Goodman D, Johnson CO, Wenzel L, Bowen D, Condit C, Edwards KL. Consent Issues in Genetic Research: Views of Research Participants. Public Health Genomics. 2016; 19(4):220-8. PMID: 27376949.
      View in: PubMed
    11. Iyer NS, Osann K, Hsieh S, Tucker JA, Monk BJ, Nelson EL, Wenzel L. Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life. Clin Ther. 2016 Mar; 38(3):467-75. PMID: 26926320; PMCID: PMC4799758 [Available on 03/01/17].
    12. Edwards KL, Korngiebel DM, Pfeifer L, Goodman D, Renz A, Wenzel L, Bowen DJ, Condit CM. Participant views on consent in cancer genetics research: preparing for the precision medicine era. J Community Genet. 2016 Apr; 7(2):133-43. PMID: 26801345; PMCID: PMC4796049.
    13. Cohn DE, Havrilesky LJ, Osann K, Lipscomb J, Hsieh S, Walker JL, Wright AA, Alvarez RD, Karlan BY, Bristow RE, DiSilvestro PA, Wakabayashi MT, Morgan R, Mukamel DB, Wenzel L. Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice. Gynecol Oncol. 2015 Sep; 138(3):712-6. PMID: 26177553; PMCID: PMC4920477.
    14. Wenzel L, Osann K, Hsieh S, Tucker JA, Monk BJ, Nelson EL. Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial. J Clin Oncol. 2015 Apr 01; 33(10):1171-9. PMID: 25713429; PMCID: PMC4372853.
    15. Chase DM, Kauderer J, Wenzel L, Ramondetta L, Cella D, Long HJ, Monk BJ. Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204. Int J Gynecol Cancer. 2015 Feb; 25(2):303-8. PMID: 25405577; PMCID: PMC4506195.
    16. Penson RT, Huang HQ, Wenzel L, Monk BJ, Stockman S, Long HJ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Method M, Michael H, Tewari KS. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). Lancet Oncol. 2015 Mar; 16(3):301-11. PMID: 25638326; PMCID: PMC4479218.
    17. Mackay HJ, Wenzel L, Mileshkin L. Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond. Am Soc Clin Oncol Educ Book. 2015; e299-309. PMID: 25993189; PMCID: PMC4920478.
    18. Pfaendler KS, Wenzel L, Mechanic MB, Penner KR. Cervical cancer survivorship: long-term quality of life and social support. Clin Ther. 2015 Jan 01; 37(1):39-48. PMID: 25592090; PMCID: PMC4404405.
    19. Chase DM, Huang H, Foss CD, Wenzel L, Monk BJ, Burger RA. Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: characteristics associated with toxicity and the effect of substitution with docetaxel: an NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2015 Feb; 136(2):323-7. PMID: 25529832.
      View in: PubMed
    20. Cohn DE, Barnett JC, Wenzel L, Monk BJ, Burger RA, Straughn JM, Myers ER, Havrilesky LJ. A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer. Gynecol Oncol. 2015 Feb; 136(2):293-9. PMID: 25449568; PMCID: PMC4512835.
    21. Osann K, Hsieh S, Nelson EL, Monk BJ, Chase D, Cella D, Wenzel L. Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials. Gynecol Oncol. 2014 Nov; 135(2):266-72. PMID: 25192629; PMCID: PMC4479396.
    22. Donovan KA, Donovan HS, Cella D, Gaines ME, Penson RT, Plaxe SC, von Gruenigen VE, Bruner DW, Reeve BB, Wenzel L. Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. J Natl Cancer Inst. 2014 Jul; 106(7). PMID: 25006190; PMCID: PMC4110471.
    23. Stockler MR, Hilpert F, Friedlander M, King MT, Wenzel L, Lee CK, Joly F, de Gregorio N, Arranz JA, Mirza MR, Sorio R, Freudensprung U, Sneller V, Hales G, Pujade-Lauraine E. Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer. J Clin Oncol. 2014 May 01; 32(13):1309-16. PMID: 24687829; PMCID: PMC4876313.
    24. Donovan HS, Nolte S, Edwards RP, Wenzel L. Nursing research in the Gynecologic Oncology Group. Semin Oncol Nurs. 2014 Feb; 30(1):44-52. PMID: 24559780; PMCID: PMC4006357.
    25. Monk BJ, Huang HQ, Burger RA, Mannel RS, Homesley HD, Fowler J, Greer BE, Boente M, Liang SX, Wenzel L. Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study. Gynecol Oncol. 2013 Mar; 128(3):573-8. PMID: 23219660; PMCID: PMC4099057.
    26. Carter J, Huang H, Chase DM, Walker JL, Cella D, Wenzel L. Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 Study. Int J Gynecol Cancer. 2012 Nov; 22(9):1624-33. PMID: 23095778; PMCID: PMC3536465.
    27. Wenzel L, Osann K, Lester J, Kurz R, Hsieh S, Nelson EL, Karlan B. Biopsychological stress factors in BRCA mutation carriers. Psychosomatics. 2012 Nov-Dec; 53(6):582-90. PMID: 23157996; PMCID: PMC4572843.
    28. Hess LM, Brady WE, Havrilesky LJ, Cohn DE, Monk BJ, Wenzel L, Cella D. Comparison of methods to estimate health state utilities for ovarian cancer using quality of life data: a Gynecologic Oncology Group study. Gynecol Oncol. 2013 Feb; 128(2):175-80. PMID: 23123576.
      View in: PubMed
    29. Chase DM, Osann K, Sepina N, Wenzel L, Tewari KS. The challenge of follow-up in a low-income colposcopy clinic: characteristics associated with noncompliance in high-risk populations. J Low Genit Tract Dis. 2012 Oct; 16(4):345-51. PMID: 22622340; PMCID: PMC4293035.
    30. Biegler KA, Anderson AK, Wenzel L, Osann K, Nelson EL. Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: implications for cancer prevention. Cancer Prev Res (Phila). 2012 Oct; 5(10):1173-82. PMID: 22827974; PMCID: PMC4479406.
    31. Chase DM, Wenzel L, Monk BJ. Quality-of-life results used to endorse changes in standard of care for recurrent platinum-sensitive ovarian cancer. Expert Rev Pharmacoecon Outcomes Res. 2012 Jun; 12(3):279-81. PMID: 22812551; PMCID: PMC4920474.
    32. Chase DM, Huang HQ, Wenzel L, Cella D, McQuellon R, Long HJ, Moore DH, Monk BJ. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 May; 125(2):315-9. PMID: 22307062.
      View in: PubMed
    33. Carter J, Penson R, Barakat R, Wenzel L. Contemporary quality of life issues affecting gynecologic cancer survivors. Hematol Oncol Clin North Am. 2012 Feb; 26(1):169-94. PMID: 22244668; PMCID: PMC4572845.
    34. Gould N, Sill MW, Mannel RS, Thaker PH, Disilvestro P, Waggoner S, Yamada SD, Armstrong DK, Wenzel L, Huang H, Fracasso PM, Walker JL. A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Apr; 125(1):54-8. PMID: 22155262; PMCID: PMC3670678.
    35. von Gruenigen VE, Huang HQ, Gil KM, Frasure HE, Armstrong DK, Wenzel L. The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol. 2012 Mar; 124(3):379-82. PMID: 22119995; PMCID: PMC3278514.
    36. Chase DM, Wenzel L. Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Rev Pharmacoecon Outcomes Res. 2011 Aug; 11(4):421-31. PMID: 21831023; PMCID: PMC4920475.
    37. McAlpine JN, Wenzel L. Survivorship as an element of clinical trials in ovarian cancer. Int J Gynecol Cancer. 2011 May; 21(4):788-92. PMID: 21543942; PMCID: PMC4920476.
    38. Osann K, Wenzel L, Dogan A, Hsieh S, Chase DM, Sappington S, Monk BJ, Nelson EL. Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial. Gynecol Oncol. 2011 Jun 01; 121(3):558-64. PMID: 21402400; PMCID: PMC4572839.
    39. Perez LA, Natividad L, Chung W, Haddock RL, Wenzel L, Hubbell FA. Social Support for Chamorro Breast Cancer Survivors on Guam. Calif J Health Promot. 2010 Dec; 8(Spec iss):63-72. PMID: 25866489.
      View in: PubMed
    40. Trimble EL, Birrer MJ, Hoskins WJ, Marth C, Petryshyn R, Quinn M, Thomas GM, Kitchener HC. Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009. Int J Gynecol Cancer. 2010 Oct; 20(7):1290-8. PMID: 21151709.
      View in: PubMed
    41. Cella D, Huang HQ, Monk BJ, Wenzel L, Benda J, McMeekin DS, Cohn D, Ramondetta L, Boardman CH. Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Dec; 119(3):531-7. PMID: 20837359; PMCID: PMC4687012.
    42. Marcus AC, Garrett KM, Cella D, Wenzel L, Brady MJ, Fairclough D, Pate-Willig M, Barnes D, Emsbo SP, Kluhsman BC, Crane L, Sedlacek S, Flynn PJ. Can telephone counseling post-treatment improve psychosocial outcomes among early stage breast cancer survivors? Psychooncology. 2010 Sep; 19(9):923-32. PMID: 19941285; PMCID: PMC2891611.
    43. von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L. A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study. J Pain Symptom Manage. 2010 May; 39(5):839-46. PMID: 20471545; PMCID: PMC3715039.
    44. Graves KD, Wenzel L, Schwartz MD, Luta G, Wileyto P, Narod S, Peshkin BN, Marcus A, Cella D, Emsbo SP, Barnes D, Halbert CH. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2010 Mar; 19(3):648-54. PMID: 20200423; PMCID: PMC2849295.
    45. Speechley M, Barton JC, Passmore L, Harrison H, Reboussin DM, Harris EL, Rivers CA, Fadojutimi-Akinsiku M, Wenzel L, Diaz S. Potential nonresponse bias in a clinical examination after initial screening using iron phenotyping and HFE genotyping in the hemochromatosis and iron overload screening study. Genet Test Mol Biomarkers. 2009 Dec; 13(6):721-8. PMID: 19860558; PMCID: PMC2935839.
    46. von Gruenigen VE, Huang HQ, Gil KM, Gibbons HE, Monk BJ, Rose PG, Armstrong DK, Cella D, Wenzel L. Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials. Cancer. 2009 Oct 15; 115(20):4857-64. PMID: 19691091; PMCID: PMC2761522.
    47. Wenzel L. Patient-reported outcomes in sentinel lymph node procedure versus inguinofemoral lymphadenectomy: what is the next step? Gynecol Oncol. 2009 Jun; 113(3):299-300. PMID: 19426884; PMCID: PMC4572834.
    48. Wenzel L, Huang HQ, Cella D, Walker JL, Armstrong DK. Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: a Gynecologic Oncology Group study. Gynecol Oncol. 2008 Jul; 110(1):60-4. PMID: 18430468; PMCID: PMC2587401.
    49. Wenzel L, Bowen D, Habbal R, Leighton N, Vu T, Anton-Culver H. Testing targeted approaches to enhance Cancer Genetics Network minority recruitment within Asian populations. Community Genet. 2008; 11(4):234-40. PMID: 18417971.
      View in: PubMed
    50. Nelson EL, Wenzel L, Osann K, Dogan-Ates A, Chantana N, Reina-Patton A, Laust AK, Nishimoto KP, Chicz-DeMet A, du Pont N, Monk BJ. Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial [corrected]. Clin Cancer Res. 2008 Apr 01; 14(7):2111-8. PMID: 18381952; PMCID: PMC4572837.
    51. Balajadia RG, Wenzel L, Huh J, Sweningson J, Hubbell FA. Cancer-related knowledge, attitudes, and behaviors among Chamorros on Guam. Cancer Detect Prev. 2008; 32 Suppl 1:S4-15. PMID: 18359579; PMCID: PMC2441600.
    52. Cruz AL, Chung W, Huh J, Blas LA, Cruz LA, Hubbell FA, Wenzel L. Breast cancer screening among Chamorro women in California. Cancer Detect Prev. 2008; 32 Suppl 1:S16-22. PMID: 18343045; PMCID: PMC2426715.
    53. Chase DM, Monk BJ, Wenzel L, Tewari KS. Supportive care for women with gynecologic cancers. Expert Rev Anticancer Ther. 2008 Feb; 8(2):227-41. PMID: 18279064.
      View in: PubMed
    54. Bruner DW, Bryan CJ, Aaronson N, Blackmore CC, Brundage M, Cella D, Ganz PA, Gotay C, Hinds PS, Kornblith AB, Movsas B, Sloan J, Wenzel L, Whalen G. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007 Nov 10; 25(32):5051-7. PMID: 17991920; PMCID: PMC4920473.
    55. Wagner LI, Wenzel L, Shaw E, Cella D. Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions. J Clin Oncol. 2007 Nov 10; 25(32):5058-62. PMID: 17991921.
      View in: PubMed
    56. Bast RC, Thigpen JT, Arbuck SG, Basen-Engquist K, Burke LB, Freedman R, Horning SJ, Ozols R, Rustin GJ, Spriggs D, Wenzel L, Pazdur R. Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop. Gynecol Oncol. 2007 Nov; 107(2):173-6. PMID: 17950384.
      View in: PubMed
    57. Wenzel L, Anderson R, Tucker DC, Palla S, Thomson E, Speechley M, Harrison H, Lewis-Jack O, Fadojutimi-Akinsiku M, Eckfeldt JH, Reiss JA, Rivers CA, Bookman E, Snively BM, McLaren CE. Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) study. Genet Med. 2007 Oct; 9(10):705-12. PMID: 18073584.
      View in: PubMed
    58. Marth C, Walker JL, Barakat RR, Casado A, Gadducci A, Miller B, Odicino F, Pujade-Lauraine E, Sehouli J, Tropé C, Wenzel L, Zeimet AG. Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer. Cancer. 2007 Feb 15; 109(4):645-9. PMID: 17238177.
      View in: PubMed
    59. Wenzel L, Huang HQ, Armstrong DK, Walker JL, Cella D. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007 Feb 01; 25(4):437-43. PMID: 17264340.
      View in: PubMed
    60. Penson RT, Wenzel L, Vergote I, Cella D. Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S247-57. PMID: 17161164.
      View in: PubMed
    61. Anderson RT, Wenzel L, Walker AP, Ruggiero A, Acton RT, Hall MA, Tucker DC, Thomson E, Harrison B, Howe E, Holup J, Leiendecker-Foster C, Power T, Adams P. Impact of hemochromatosis screening in patients with indeterminate results: the hemochromatosis and iron overload screening study. Genet Med. 2006 Nov; 8(11):681-7. PMID: 17108759.
      View in: PubMed
    62. Penson RT, Wenzel L, Vergote I, Cella D. Quality of Life Considerations in Gynecologic Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S247-S257. PMID: 29644666.
      View in: PubMed
    63. Hubbell FA, Luce PH, Afeaki WP, Cruz LA, McMullin JM, Mummert A, Pouesi J, Reyes ML, Taumoepeau LT, Tu'ufuli GM, Wenzel L. Legacy of the Pacific Islander cancer control network. Cancer. 2006 Oct 15; 107(8 Suppl):2091-8. PMID: 16981187.
      View in: PubMed
    64. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006 Jan 05; 354(1):34-43. PMID: 16394300.
      View in: PubMed
    65. Anderson RT, Press N, Tucker DC, Snively BM, Wenzel L, Ellis SD, Hall MA, Walker AP, Thomson EJ, Lewis-Jack O, Acton RT. Patient acceptability of genotypic testing for hemochromatosis in primary care. Genet Med. 2005 Oct; 7(8):557-63. PMID: 16247294.
      View in: PubMed
    66. Wenzel L, Huang HQ, Monk BJ, Rose PG, Cella D. Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2005 Aug 20; 23(24):5605-12. PMID: 16110020; PMCID: PMC4920482.
    67. Penson R, Cella D, Wenzel L. Quality of life in ovarian cancer. J Reprod Med. 2005 Jun; 50(6):407-16. PMID: 16050565.
      View in: PubMed
    68. Wenzel L, DeAlba I, Habbal R, Kluhsman BC, Fairclough D, Krebs LU, Anton-Culver H, Berkowitz R, Aziz N. Quality of life in long-term cervical cancer survivors. Gynecol Oncol. 2005 May; 97(2):310-7. PMID: 15863123.
      View in: PubMed
    69. Wenzel L, Dogan-Ates A, Habbal R, Berkowitz R, Goldstein DP, Bernstein M, Kluhsman BC, Osann K, Newlands E, Seckl MJ, Hancock B, Cella D. Defining and measuring reproductive concerns of female cancer survivors. J Natl Cancer Inst Monogr. 2005; (34):94-8. PMID: 15784834.
      View in: PubMed
    70. Hubbell FA, Luce PH, Afeaki WP, Cruz LA, Gumataotao T, McMullin JM, Pouesi J, Reyes ML, Taumoepeau LT, Tu'ufuli GM, Wenzel L. Addressing the cancer control needs of Pacific Islanders: experience of the Pacific Islander Cancer Control Network. Pac Health Dialog. 2004 Sep; 11(2):233-8. PMID: 16281706.
      View in: PubMed
    71. Wenzel L, Berkowitz RS, Habbal R, Newlands E, Hancock B, Goldstein DP, Seckl M, Bernstein M, Strickland S, Higgins J. Predictors of quality of life among long-term survivors of gestational trophoblastic disease. J Reprod Med. 2004 Aug; 49(8):589-94. PMID: 15457848.
      View in: PubMed
    72. Halbert CH, Schwartz MD, Wenzel L, Narod S, Peshkin BN, Cella D, Lerman C. Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med. 2004 Aug; 27(4):373-92. PMID: 15559734.
      View in: PubMed
    73. Halbert CH, Wenzel L, Lerman C, Peshkin BN, Narod S, Marcus A, Corio C, Demarco T, Bellamy S. Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):875-81. PMID: 15159322.
      View in: PubMed
    74. Tinley ST, Houfek J, Watson P, Wenzel L, Clark MB, Coughlin S, Lynch HT. Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. Am J Med Genet A. 2004 Feb 15; 125A(1):5-11. PMID: 14755459.
      View in: PubMed
    75. Garner E, Goldstein DP, Berkowitz RS, Wenzel L. Psychosocial and reproductive outcomes of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003 Dec; 17(6):959-68. PMID: 14614892.
      View in: PubMed
    76. Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel L, Bodurka DC. Cervical cancer. Cancer. 2003 Nov 01; 98(9 Suppl):2009-14. PMID: 14603537.
      View in: PubMed
    77. Wenzel L, Vergote I, Cella D. Quality of life in patients receiving treatment for gynecologic malignancies: special considerations for patient care. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:211-29. PMID: 14763177.
      View in: PubMed
    78. Coyne CA, Xu R, Raich P, Plomer K, Dignan M, Wenzel L, Fairclough D, Habermann T, Schnell L, Quella S, Cella D. Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. J Clin Oncol. 2003 Mar 01; 21(5):836-42. PMID: 12610182.
      View in: PubMed
    79. Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol. 2002 Nov; 21(6):564-72. PMID: 12433008.
      View in: PubMed
    80. Wenzel L, Berkowitz RS, Newlands E, Hancock B, Goldstein DP, Seckl MJ, Habbal R, Bernstein M, Kluhsman B, Kulchak-Rahm A, Strickland S, Higgins J. Quality of life after gestational trophoblastic disease. J Reprod Med. 2002 May; 47(5):387-94. PMID: 12063877.
      View in: PubMed
    81. Wenzel L, Donnelly JP, Fowler JM, Habbal R, Taylor TH, Aziz N, Cella D. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psychooncology. 2002 Mar-Apr; 11(2):142-53. PMID: 11921330.
      View in: PubMed
    82. Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet. 2002 Jan 15; 107(2):143-50. PMID: 11807889.
      View in: PubMed
    Lari's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _